These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11249591)

  • 61. [New achievements in the fluoroquinolone problem: possibilities of increasing activity and expansion of the spectrum of action].
    Padeĭskaia EN
    Antibiot Khimioter; 1994 May; 39(5):52-65. PubMed ID: 7857163
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro and in vivo antibacterial activities of CFC-222, a novel broad spectrum fluoroquinolone.
    Park KH; Cho IH; Lee JM; Kang JA; Kim YG; Hong KH; Kim JH; Nishino T
    Drugs; 1995; 49 Suppl 2():240-2. PubMed ID: 8549317
    [No Abstract]   [Full Text] [Related]  

  • 63. Fluoroquinolone treatment of Enterococcus infection.
    Fish DN; Rodvold KA
    Ann Pharmacother; 1992 Apr; 26(4):498-500. PubMed ID: 1576389
    [No Abstract]   [Full Text] [Related]  

  • 64. [The present status and future perspectives of fluorinated quinolones from the aspect of clinical microbiology].
    Lochmann O
    Cas Lek Cesk; 1997 Mar; 136(6):191-5. PubMed ID: 9221193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The return of gram-positive bacteria].
    Romero J; Picazo JJ
    Enferm Infecc Microbiol Clin; 1993 May; 11(5):231-4. PubMed ID: 8324017
    [No Abstract]   [Full Text] [Related]  

  • 66. Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.
    Fischetti VA
    Int J Med Microbiol; 2010 Aug; 300(6):357-62. PubMed ID: 20452280
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Bacterial resistance to fluoroquinolones: mechanisms and patterns.
    Hooper DC
    Adv Exp Med Biol; 1995; 390():49-57. PubMed ID: 8718601
    [No Abstract]   [Full Text] [Related]  

  • 68. Integrating fluoroquinolones into the hospital formulary.
    Bertino JS
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):273S-283S. PubMed ID: 11642692
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Indications and restrictions of fluoroquinolone use in children.
    Green SD
    Br J Hosp Med; 1996 Oct 16-Nov 5; 56(8):420-3. PubMed ID: 8909718
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gram-positive infections and quinolones in neutropenia.
    Castagnola E; Viscoli C
    Ann Intern Med; 1997 May; 126(10):830-1. PubMed ID: 9148666
    [No Abstract]   [Full Text] [Related]  

  • 71. Gram-positives towards the year 2000.
    Moellering RC
    Drugs; 1997; 54 Suppl 6():1-3. PubMed ID: 9474475
    [No Abstract]   [Full Text] [Related]  

  • 72. Newer-generation fluoroquinolone antibiotics.
    Hedge DD
    S D J Med; 1998 Sep; 51(9):349-50. PubMed ID: 9757793
    [No Abstract]   [Full Text] [Related]  

  • 73. Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.
    Poole K
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2233-41. PubMed ID: 10952561
    [No Abstract]   [Full Text] [Related]  

  • 74. [Resistance to antibiotics in gram-positive bacteria from blood cultures].
    Jensen KT; Scheel O
    Ugeskr Laeger; 1988 Dec; 150(49):3056-8. PubMed ID: 3201627
    [No Abstract]   [Full Text] [Related]  

  • 75. Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline.
    Kocsis B; Gulyás D; Szabó D
    Antibiotics (Basel); 2021 Dec; 10(12):. PubMed ID: 34943718
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The future of fluoroquinolones.
    Drlica K
    Ann Med; 2000 Dec; 32(9):585-7. PubMed ID: 11209964
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Classification of fluoroquinolones.
    Naber KG; Adam D
    Int J Antimicrob Agents; 1998 Nov; 10(4):255-7. PubMed ID: 9916897
    [No Abstract]   [Full Text] [Related]  

  • 78. Fluoroquinolone resistance: overuse of fluoroquinolones in human and veterinary medicine can breed resistance.
    Piddock LJ
    BMJ; 1998 Oct; 317(7165):1029-30. PubMed ID: 9774285
    [No Abstract]   [Full Text] [Related]  

  • 79. Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis.
    Comstock TL; Karpecki PM; Morris TW; Zhang JZ
    Clin Ophthalmol; 2010 Apr; 4():215-25. PubMed ID: 20463787
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Fluoroquinolone carboxylic acids: is research on the development of resistance becoming invalidated?].
    Wiedemann B; Heisig P
    Pharm Unserer Zeit; 1993 Nov; 22(5-6):286-95. PubMed ID: 8121930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.